Latest Breaking News On - Anjarium biosciences - Page 2 : comparemela.com

Extracellular vesicles enhance cancer immunotherapy

Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumors sensitive to a type of immunotherapy drug called a checkpoint inhibitor.

Karolinska institutetSusanne gabrielssonAnjarium biosciencesEmily hendersonCancer immunology researchLung foundationSwedish research councilSwedish cancer societyCancer research funds of radiumhemmetDepartment of medicine solnaIndustry focusCancer research fundsRegion stockholmSwedish heart lung foundationCancer therapyImmune system

Cellular messengers improve cancer therapy

Cellular messengers improve cancer therapy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Karolinska institutetSusanne gabrielssonAnjarium biosciencesMikaelci karlssonPia larssenStefan zimmermanRosannee veermanAndreas lundqvistCancer immunology researchLung foundationSwedish research councilSwedish cancer societyCancer research funds of radiumhemmetDepartment of medicine solnaCancer research fundsRegion stockholm

Cellular Messengers Enhance Cancer Treatment

Cellular Messengers Enhance Cancer Treatment
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Pia larssenKarolinska institutetSusanne gabrielssonRosannee veermanAnjarium biosciencesMikaelci karlssonAndreas lundqvistCancer immunology researchLung foundationSwedish research councilSwedish cancer societyCancer research funds of radiumhemmetDepartment of medicine solnaCancer research fundsRegion stockholmSwedish heart lung foundation

Anjarium Biosciences appoints ex-Novartis gene therapy leader Otmane Boussif, DSc as Chief Technology Officer

ZURICH, Dec. 8, 2022 /PRNewswire/ Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today announces the appointment

Eleanor perkinGeorge underwoodStephen yooAnjarium biosciencesOtmane boussifPrnewswire anjarium biosciencesKostenloser wertpapierhandelLouis pasteurGlobal head of early phase developmentChief technology officerGlobal headGene therapy technical developmentEarly phaseGene therapyInvestigational new drugApplied biological

Anjarium Biosciences Appoints Gaurav Shah as Chairperson and Douglas Fambrough as Non-executive Director

Board expansion brings significant additional gene therapy and corporate development expertise to AnjariumZURICH, Oct. 18, 2022 /PRNewswire/ Anjarium Biosciences AG ("Anjarium"), a biotech

United statesEleanor perkinDouglas fambroughGaurav shahGeorge underwoodStephen yooAnjarium biosciencesEli lillySloan ketteringBali muralidharPrnewswire anjarium biosciencesKostenloser wertpapierhandelBram vanparysDina chaya moghrabiDoug fambroughUniversity of california